Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.95p

Change Today:

-0.15p
52 Week High: 7.10
52 Week Low: 1.93

Currency: UK Pounds
Shares Issued: 274.89m
Volume: 417,085

Market Cap: £5.36m
RiskGrade: 304

Trade now with Barclays Stockbrokers

Update - Evgen Pharma is down today can you capitalise from spread betting? Find out more
Update - Evgen Pharma is a top faller in its sector - can you take advantage with spread betting? Find out more

Latest ShareCast News

Evgen Pharma doses first volunteers in SFX-01 trial

By Josh White

Date: Wednesday 16 Nov 2022

(Sharecast News) - Clinical-stage drug developer Evgen Pharma has dosed the first group of healthy volunteers in its placebo-controlled, dose-escalating, randomised phase 1 and 1b clinical trial, it announced on Wednesday.

Read full story

News Channel

Evgen starts recruiting volunteers for trial of lead asset

By Josh White

Date: Wednesday 12 Oct 2022

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced the start of recruitment for the pharmacokinetic and pharmacodynamic trial in healthy volunteers, and the decision to commence an investigator-sponsored clinical study for the glioblastoma programme on Wednesday.

Read full story

News Channel

Evgen agrees fresh licensing deal with Spanish institutions

By Josh White

Date: Tuesday 18 Jan 2022

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced a memorandum of understanding with the University of Seville, Consejo Superior de Investigaciones Científicas (CSIC) and Fundación Pública Andaluza Progreso y Salud on behalf of the Institute of Biomedicine of Seville on Tuesday, for second-generation sulforaphane analogues.

Read full story

News Channel

Evgen pleased with preclinical data on SFX-01	13-Jul-2021	ShareCast
Evgen 'surprised and disappointed' by findings i...	09-Jul-2021	ShareCast
Evgen upbeat on new data on potential breast can...	14-Jun-2021	ShareCast
Evgen appoints Helen Kuhlman as chief business o...	22-Mar-2021	ShareCast
Evgen Covid-19 trial given all-clear on safety a...	11-Mar-2021	ShareCast
Evgen makes progress with recruitment in 'STAR' ...	17-Feb-2021	ShareCast
Evgen announces positive preclinical data for SF...	22-Jan-2021	ShareCast
Evgen reports 'highly positive' data from SFX-01...	21-Jan-2021	ShareCast
Evgen Pharma makes progress with 'STAR' trial re...	19-Jan-2021	ShareCast
Evgen Pharma performs in line with forecasts in ...	10-Dec-2020	ShareCast
Evgen doses first patients in 'STAR' respiratory...	23-Nov-2020	ShareCast
Evgen gets full approval for SFX-01 trial in Cov...	23-Oct-2020	ShareCast
Evgen Pharma licences technology to Juvenescence	15-Sep-2020	ShareCast
Evgen's 'SFX-01' to be tested with Covid-19 pati...	17-Jun-2020	ShareCast
Losses widen as Evgen Pharma develops SFX-01	15-Jun-2020	ShareCast
Evgen Pharma in talks about funding for Covid-19...	15-May-2020	ShareCast
Evgen Pharma narrows loss, foresees 'clinical su...	17-Dec-2019	ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Evgen Pharma Market Data

Currency	UK Pounds
Share Price	1.95p
Change Today	-0.15p
% Change	-7.14 %
52 Week High	7.10
52 Week Low	1.93
Volume	417,085
Shares Issued	274.89m
Market Cap	£5.36m
RiskGrade	304